All articles tagged with #induced pluripotent stem cells
Keck Medicine of USC leads an early-stage trial testing induced pluripotent stem cells engineered to become dopamine-producing brain cells, implanted into the basal ganglia to restore dopamine and motor function in Parkinson’s disease; the 12-participant, multi-site study monitors safety and efficacy for 12–15 months after surgery, with up to five years of follow-up.
A groundbreaking clinical trial in Japan has successfully used induced pluripotent stem cells (iPSCs) to restore vision in patients with limbal stem cell deficiency (LSCD), a condition causing corneal damage. The trial involved transplanting iPSC-derived corneal epithelial cell sheets onto the corneas of four patients, resulting in significant vision improvements for three of them. This marks a world-first achievement in stem cell research, offering hope for new treatments for corneal vision loss, though further research is needed to ensure safety and efficacy.
A groundbreaking stem cell treatment has successfully restored vision in patients with cornea damage, marking a significant advancement in eye care. The treatment involves using induced pluripotent stem cells to create corneal epithelial cells, which are then transplanted onto the damaged cornea. In a study involving four patients, three experienced lasting vision improvements, while one saw temporary benefits. The procedure showed no severe side effects or immune rejection, paving the way for further clinical trials to assess its efficacy.